{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["GcMAF", "Immunotherapy", "colostrum MAF", "macrophage activating factor (MAF)", "non-small cell lung cancer", "ozone therapy", "sonodynamic therapy (SDT)", "tumor treating field (TTF) therapy"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "27354652", "DateCompleted": {"Year": "2017", "Month": "01", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "1791-7530", "JournalIssue": {"Volume": "36", "Issue": "7", "PubDate": {"Year": "2016", "Month": "Jul"}}, "Title": "Anticancer research", "ISOAbbreviation": "Anticancer Res"}, "ArticleTitle": "Case Report: A Non-small Cell Lung Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Tumor Treating Fields.", "Pagination": {"StartPage": "3767", "EndPage": "3770", "MedlinePgn": "3767-70"}, "Abstract": {"AbstractText": ["Macrophage activating factor (MAF)-based immunotherapy has a wide application for use in treating many diseases via macrophage activation. Sonodynamic therapy (SDT) using low-intensity ultrasound and tumor treating field (TTF) therapy are novel therapeutic modalities. SDT is usually combined with ozone therapy to improve local hypoxia within the tumor environment.", "We treated a 77-year-old male diagnosed with non-small cell lung cancer ((NSCLC) stage 3B) using second-generation serum GcMAF and oral colostrum MAF-based immunotherapy combined with SDT, TTF and ozone therapies.", "This case report demonstrates that GcMAF, oral colostrum MAF, SDT, TTF and ozone therapy can be used for NSCLC without adverse effects.", "This case report suggests a new concept of cancer treatment using local destruction of cancer tissue, in this case conducted with SDT and TTF therapy, to be used in combination with serum GcMAF and colostrum MAF immunotherapy as a systemic treatment."], "CopyrightInformation": "Copyright\u00a9 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life System, Institute of Technology and Science, Graduate School, Tokushima University, Tokushima, Japan Saisei Mirai Cell Processing Center, Osaka, Japan Kobe Saisei Mirai Clinic, Kobe, Japan Inui Immunotherapy Clinic, Osaka, Japan Tokyo Saisei Mirai Clinic, Tokyo, Japan contact@saisei-mirai.or.jp."}], "LastName": "Inui", "ForeName": "Toshio", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychosomatic Internal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan."}], "LastName": "Amitani", "ForeName": "Haruka", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Saisei Mirai Cell Processing Center, Osaka, Japan."}], "LastName": "Kubo", "ForeName": "Kentaro", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life System, Institute of Technology and Science, Graduate School, Tokushima University, Tokushima, Japan Saisei Mirai Cell Processing Center, Osaka, Japan."}], "LastName": "Kuchiike", "ForeName": "Daisuke", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life System, Institute of Technology and Science, Graduate School, Tokushima University, Tokushima, Japan."}], "LastName": "Uto", "ForeName": "Yoshihiro", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Frontiers of Innovative Research in Science and Technology (FIRST), Konan University, Kobe, Japan."}], "LastName": "Nishikata", "ForeName": "Takahito", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Inui Immunotherapy Clinic, Osaka, Japan contact@saisei-mirai.or.jp."}], "LastName": "Mette", "ForeName": "Martin", "Initials": "M"}], "PublicationTypeList": ["Case Reports", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Anticancer Res", "NlmUniqueID": "8102988", "ISSNLinking": "0250-7005"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Macrophage-Activating Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "Vitamin D-Binding Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "vitamin D-binding protein-macrophage activating factor"}, {"RegistryNumber": "04Q9AIZ7NO", "NameOfSubstance": "Pemetrexed"}, {"RegistryNumber": "0W860991D6", "NameOfSubstance": "Deoxycytidine"}, {"RegistryNumber": "BG3F62OND5", "NameOfSubstance": "Carboplatin"}, {"RegistryNumber": "0", "NameOfSubstance": "Gemcitabine"}], "MeshHeadingList": [{"QualifierName": ["diagnostic imaging", "drug therapy", "pathology"], "DescriptorName": "Adenocarcinoma"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Carboplatin"}, {"QualifierName": ["diagnostic imaging", "drug therapy", "pathology"], "DescriptorName": "Carcinoma, Non-Small-Cell Lung"}, {"QualifierName": [], "DescriptorName": "Combined Modality Therapy"}, {"QualifierName": ["administration & dosage", "analogs & derivatives"], "DescriptorName": "Deoxycytidine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["diagnostic imaging", "drug therapy", "pathology"], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Macrophage-Activating Factors"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Pemetrexed"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": [], "DescriptorName": "Ultrasonic Therapy"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Vitamin D-Binding Protein"}, {"QualifierName": [], "DescriptorName": "Gemcitabine"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "4", "Day": "5"}, {"Year": "2016", "Month": "5", "Day": "11"}, {"Year": "2016", "Month": "6", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "6", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "27", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27354652", "36/7/3767"]}}], "PubmedBookArticle": []}